What is NDC 39822-0151?

39822-0151 is the product NDC for Liothyronine Sodium, Liothyronine sodium 10 ug/mL injection, solution, listed with the FDA by XGen Pharmaceuticals DJB, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

XGen Pharmaceuticals DJB, Inc., NDC labeler code 39822. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Liothyronine Sodium?

44 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Liothyronine Sodium NDC 39822-0151 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)39822-0151Labeler and product segments. Claims need a package NDC.

Product NDC at billing width39822-0151Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
39822-0151-1	39822015101	1 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIALMarketed from Aug 17, 2005

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Liothyronine Sodium
Generic name (nonproprietary): liothyronine sodium
Active ingredients: Liothyronine sodium — 10 ug/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: XGen Pharmaceuticals DJB, Inc.NDC labeler code 39822
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076923
Marketing start: Aug 17, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Triiodothyronine (Chemical structure)
Identifiers: Product ID 39822-0151_02f79412-2198-a8af-e063-6394a90a0853SPL ID 02f79412-2198-a8af-e063-6394a90a0853SPL set ID a8b39730-de19-497d-bde8-6594aa528403RxCUI 903694UNII GCA9VV7D2N
Pharmacologic class: l-Triiodothyronine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N439822015101 followed by a unit qualifier and the quantity

Package 39822-0151-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 1, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Liothyronine sodium injection (T 3 ) is indicated in the treatment of myxedema coma/precoma. Liothyronine sodium injection (T 3 ) can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 39822-0151

What is NDC 39822-0151?: 39822-0151 is the product NDC for Liothyronine Sodium, Liothyronine sodium 10 ug/mL injection, solution, listed with the FDA by XGen Pharmaceuticals DJB, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Liothyronine Sodium.
What is the active ingredient?: Liothyronine sodium.
Who is the labeler?: XGen Pharmaceuticals DJB, Inc., NDC labeler code 39822. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Liothyronine Sodium?: 44 other product NDCs are listed under this name. See all Liothyronine Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Liothyronine Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Liothyronine Sodium	Liothyronine sodium 50 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-004	75907-0004-01
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-001	75907-0001-01
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-039	75907-0039-01
Liothyronine sodium	Liothyronine sodium 5 ug/1	TabletOral	Biocon Pharma Inc.	70377-114	70377-0114-1170377-0114-1270377-0114-13
Liothyronine sodium	Liothyronine sodium 25 ug/1	TabletOral	Biocon Pharma Inc.	70377-115	70377-0115-1170377-0115-1270377-0115-13
Liothyronine sodium	Liothyronine sodium 50 ug/1	TabletOral	Biocon Pharma Inc.	70377-116	70377-0116-1170377-0116-1270377-0116-13
Liothyronine sodium	Liothyronine sodium 25 ug/1	TabletOral	Northstar Rx LLC	16714-167	16714-0167-01
Liothyronine sodium	Liothyronine sodium 5 ug/1	TabletOral	Northstar Rx LLC	16714-166	16714-0166-01
Liothyronine sodium	Liothyronine sodium 50 ug/1	TabletOral	Northstar Rx LLC	16714-168	16714-0168-01
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-2178	00093-2178-01

All 45 Liothyronine Sodium NDCs